摘要
目的:探讨静脉溶栓治疗急性心肌梗死(AMI)的临床效果。方法:应用尿激酶进行静脉溶栓治疗早期AMI患者160例。结果:本组108例再通,再通率为67.5%。其中6h内AMI患者再通94例,再通率为87.0%(94/108)。本组死亡4例,死亡率为2.5%。结论:对于AMI患者,只要具有溶栓指征而无禁忌证,应尽可能早地应用尿激酶进行静脉溶栓,再通率高,副作用小,值得推广应用。
Objective： To explore the clinical effect of intravenous thrombolytic therapy on acute myocardial infarction （ACI）. Methods： Intravenous urokinase thrombolysis was applied to treat 160 cases of patients with early AMI. Results： There were 108 cases of recanalization in this group, the recanalization rate was 67.5%. Among these cases, 94 cases of patients with AMI developed recanalization within 6 h, the recanalization rate was 87.0% （94/108）. 4 cases died in this group, the mortality rate was 2.5%. Conclusion： For patients with AMI as long as with thrombolytic therapy and without contraindications indications, the application of intravenous urokinase thrombolysis should be developed as soon as possible, the recanalization rate is high, the side effects is tiny, and it is worth popularizing.
出处
《中国医药导报》
CAS
2009年第23期21-22,共2页
China Medical Herald
关键词
急性心肌梗死
静脉溶栓
尿激酶
再通
并发症
Acute myocardial infarction
Intravenous thrombolysis
Urokinase
Recanalization
Complications
